MAPT and amyloidosis: Given the observation that TDP-43 co-pathology is much more common in the presence of ADNC than in pure tauopathies such as FTLD-tau, progressive supranuclear palsy, or corticobasal syndrome, there may be an interaction between amyloid and TDP-43.